Merck acquires AmpTec to expand mRNA capabilities for vaccines, treatments and diagnostics
Diagnostics business focused on producing customized long RNAs and DNAs for in vitro diagnostics, complements existing Merck portfolio
Diagnostics business focused on producing customized long RNAs and DNAs for in vitro diagnostics, complements existing Merck portfolio
As SARS-CoV-2 vaccines become available, Siemens Healthineers is ready with fully automated antibody tests that can be used to help inform whether broad vaccination programs are working
The modular solution aims to deliver test results in a four-step process requiring minimal hands-on time, laboratory space and staffing resources
With cases rising among younger adults in India, researchers race to develop predictive diagnostics and immune-informed therapies
Watch this on-demand webinar to find out how to maximize the outcome of LC-PDA-MS analysis and reduce data analysis time
Future-proofing the Biopharmaceutical QC Laboratory: Using the ACQUITY UPLC H-Class Bio System to Run SEC-HPLC and SEC-UPLC
Measuring Reactive Oxygen Species with SpectraMax Microplate Readers
Recombinant proteins specifically relevant as E3 ligases or target proteins for Proteolysis Targeting Chimeras (PROTACs), enabling the development of this novel targeted protein degradation technology.
Pump from HNP Mikrosysteme ensures a constant sheath flow